ORIGINAL RESEARCH
Published on 26 Nov 2025
Preoperative TACE with PD-1 inhibitors and TKIs in beyond “up-to-seven” hepatocellular carcinoma: a propensity score matched analysis
doi 10.3389/fimmu.2025.1657371
- 190 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Integrating Molecular Mechanisms, Immunotherapy, and Drug Sensitivity in Cancer Immunology and Oncology
Integrating Molecular Mechanisms, Immunotherapy, and Drug Sensitivity in Cancer Immunology and Oncology
30k
Total downloads
123k
Total views and downloads
Articles
MINI REVIEW
Published on 28 Oct 2025
Integrated molecular and microenvironmental drivers of drug resistance in gastrointestinal cancers: mechanisms, immunotherapy challenges, and precision strategies
doi 10.3389/fonc.2025.1675745
- 1,134 views
ORIGINAL RESEARCH
Published on 13 Oct 2025
Chromosome 11q13 amplification as a decision-making biomarker for anti-PD-1 immunotherapy in recurrent or metastatic head and neck squamous cell carcinoma: a prospective cohort study
doi 10.3389/fimmu.2025.1667733
- 964 views
ORIGINAL RESEARCH
Published on 22 Sep 2025
SLFN11 expression correlates with immune microenvironment and predicts prognosis in melanoma
doi 10.3389/fimmu.2025.1607056
- 2,533 views
ORIGINAL RESEARCH
Published on 03 Sep 2025
Physicochemical and biological characterization of a bispecific antibody in a CrossMab/KIH format that targets EGFR and VEGF-A
doi 10.3389/fimmu.2025.1659966
- 2,131 views
MINI REVIEW
Published on 01 Sep 2025
Sepsis-driven metabolic reprogramming shapes cancer immunotherapy efficacy, metastatic potential, and drug sensitivity
doi 10.3389/fimmu.2025.1642477
- 1,558 views
ORIGINAL RESEARCH
Published on 24 Jul 2025
Identification of a coagulation-related classification and signature that predict disease heterogeneity for colorectal cancer and pan-cancer patients
doi 10.3389/fimmu.2025.1572701
- 1,938 views
ORIGINAL RESEARCH
Published on 15 Jul 2025
Targeting the KLF5/PI3K/AKT axis as a therapeutic strategy to overcome neoadjuvant chemoresistance in colorectal cancer
doi 10.3389/fimmu.2025.1593639
- 2,179 views
- 1 citation
ORIGINAL RESEARCH
Published on 14 Jul 2025
Real-world data of cadonilimab in recurrent or metastatic cervical cancer in China: a multicentric study
doi 10.3389/fimmu.2025.1611696
- 2,068 views
ORIGINAL RESEARCH
Published on 26 Jun 2025
Multi-omics analysis reveals the role of ribosome biogenesis in malignant clear cell renal cell carcinoma and the development of a machine learning-based prognostic model
doi 10.3389/fimmu.2025.1602898
- 3,391 views
- 1 citation
ORIGINAL RESEARCH
Published on 24 Jun 2025
Taurine-mediated metabolic immune crosstalk indicates and promotes immunosuppression with anti-PD-1 resistance in bladder cancer
doi 10.3389/fimmu.2025.1618439
- 3,448 views
- 1 citation
ORIGINAL RESEARCH
Published on 09 Jun 2025
Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status
doi 10.3389/fonc.2025.1596156
- 1,590 views
- 3 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore